Special Issue “Advance in Tick-Borne Diseases Research”

JUL 1, 2020 — 

———- Original Message ———-

Cc: (98 undisclosed recipients)
Date: 06/30/2020 12:54 PM
Subject: Special Issue “Advance in Tick-Borne Diseases Research”

To the Tick-borne Disease Working Group,

Here is more evidence of the global denial of persistent infection after extensive antibiotic treatment. Academics along with the US Centers for Disease Control who have followed Dr. Gary Wormser’s racketeering scheme are aiding and abetting this scientific misconduct.

Please see the following email addressed to Professors Stanek and Strle with cc; to Managing Editor, Ms. Ashlynn Wang, Microorganisms.

Carl Tuttle
———- Original Message ———-
Date: 06/29/2020 11:59 AM
Subject: Special Issue “Advance in Tick-Borne Diseases Research”

Microorganisms — Open Access Journal

Special Issue “Advance in Tick-Borne Diseases Research”

Special Issue Editors: -Prof. Dr. Gerold Stanek , -Prof. Dr. Franc Strle  

June 29, 2020

Immunology of Infection and Microbiology
Institute for Hygiene and Applied Immunology
Center for Pathophysiology, Infectiology and Immunology
Kinderspitalgasse 15, 1090 Vienna, Austria
Attn: Prof. Dr. Gerold Stanek and Prof. Dr. Franc Strle

To: Professors Stanek and Strle,

It should be known that the academics in the United States who have controlled the Lyme disease narrative for the past thirty years are defendants in a racketeering lawsuit in Texas District Court. Four of the eight insurance companies named in this suit have now settled out of court and the court has upheld the racketeering charge.

Court upholds claims under RICO, against doctor defendants

One of the strategies of this racketeering scheme was to suppress evidence of persistent infection after extensive antibiotic treatment and then claim there is no evidence.

Dr. Gary Wormser of New York Medical College has had a global influence on the scientific community promoting his groupthink mentality concerning persistent Borrelia infection. (Wormser; “Chronic Lyme disease does not exist”)

Dr. Stanek, you clearly reported persistent Borrelia infection in 2001 in a 64-year-old patient despite treatment with four courses of ceftriaxone [1] but when Dr. Wormser teamed up with you and Dr. Strle in 2012 that case of chronic Lyme was omitted in your Lancet article and you and your coauthors claim that Lyme disease is easily treated. [2]

Here is a quote from your 2001 publication identifying persistent infection:

“Borrelia [the Lyme disease bacteria] may possibly be able to remain dormant in certain tissue compartments”

Here is a quote from your 2012 lancet article:

“Most manifestations of Lyme borreliosis will resolve spontaneously without treatment.”

In 2014 you and Dr. Strle published the following paper promoting antibiotic treatment:

Lyme Borreliosis (Book Chapter)   [no longer at this original link]

Stupica, D. a,  Stanek, G. b,  Strle, F. a

a  Department of Infectious Diseases, University Medical Centre Ljubljana, Ljubljana, Slovenia
b  Institute for Hygiene and Applied Immunology, Medical University of Vienna, Austria


A 49-year-old male, living in a Lyme borreliosis (LB) endemic region, noticed an erythematous skin rash about 10 days after a bite that in the next 2 weeks evolved to a ring-like skin lesion with diameters of 18×9. cm, i.e., presenting as typical erythema migrans (EM). The lesion disappeared spontaneously in 5 weeks; however, in the following 2 months the patient developed radicular pains, complete heart block that required insertion of transient heart pacemaker, and knee arthritis. Cerebrospinal fluid (CSF) analysis revealed lymphocytic pleocytosis. High levels of serum and CSF borrelial IgG antibodies and intrathecal production of the specific antibodies were ascertained, and treatment with ceftriaxone 2. g OD intravenously for 14 days was initiated. The patient regained his physical capacity, radicular chest pain and knee swelling declined, and heart conduction abnormalities resolved. The pacemaker was removed during antibiotic treatment, and the patient’s further course was uneventful. The patient had all major manifestations of LB, which could have been prevented if EM had been recognized and properly treated. However, instead of antibiotic treatment, the physician who saw the patient at the time of EM ordered tests for the presence of borrelial antibodies, and misinterpreted negative serology as an indication against antibiotic treatment.LB is the most frequent tick-transmitted illness on the Northern Hemisphere. It is caused by certain species of Lyme borreliae. In the present report, epidemiology, etiology, mode of transmission, pathogenesis, clinical features, diagnosis and differential diagnosis, treatment and prevention of this emerging disease with increasing incidence are discussed. © 2014 Elsevier Inc. All rights reserved.

So, let’s review your position:

  • In 2001 you identified chronic Lyme disease
  • in 2012 you claimed Lyme is a simple nuisance disease
  • In 2014 Lyme became very serious requiring the insertion of transient heart pacemaker

So what’s going on here Dr. Stanek?

Have you become influenced by Dr. Gary Wormser (who is a defendant in an alleged racketeering scheme) promoting the global denial of persistent Borrelia infection and misclassification as a simple nuisance disease?

Patient testimony all across America [3] (and the globe) [4] is describing a disease that is destroying lives, ending careers while leaving its victim in financial ruin.

For the record: The maximum penalty authorized for a RICO violation here in the United States is 20 years in jail.

A response to this inquiry is requested.

Respectfully submitted,

Carl Tuttle

Lyme Endemic Hudson, NH USA

Cc: Ms. Ashlynn Wang, Managing Editor, Microorganisms
Dr. Unai Vicario, Publishing Manager , MDPI
Shu-Kun Lin, Ph.D. President, MDPI
Franck Vazquez, Ph.D., Chief Scientific Officer, MDPI


1. Br J Dermatol. 2001 Feb;144(2):387-92.

Isolation and polymerase chain reaction typing of Borrelia afzelii from a skin lesion in a seronegative patient with generalized ulcerating bullous lichen sclerosus et atrophicus.

Breier F ,  Khanakah G,  Stanek G,  Kunz G,  Aberer E,  Schmidt B,  Tappeiner G.

Author information

1Department of Dermatology, Lainz Municipal Hospital, Wolkersbergenstrasse 1, A-1130 Vienna, Austria.


A 64-year-old woman presented with bullous and ulcerating lichen sclerosus et atrophicus (LSA) on the neck, trunk, genital and perigenital area and the extremities. Histology of lesional skin showed the typical manifestations of LSA; in one of the biopsies spirochaetes were detected by silver staining.  Despite treatment with four courses of ceftriaxone with or without methylprednisone for up to 20 days, progression of LSA was only stopped for a maximum of 1 year. Spirochaetes were isolated from skin cultures obtained from enlarging LSA lesions. These spirochaetes were identified as Borrelia afzelii by sodium dodecyl sulphate–polyacrylamide gel electrophoresis and polymerase chain reaction (PCR) analyses. However, serology for B. burgdorferi sensu lato was repeatedly negative. After one further 28-day course of ceftriaxone the lesions stopped expanding and sclerosis of the skin was diminished. At this time cultures for spirochaetes and PCR of lesional skin for B. afzelii DNA remained negative. These findings suggest a pathogenetic role for B. afzelii in the development of LSA and a beneficial effect of appropriate antibiotic treatment.

PMID: 11251580

2. Lyme borreliosis.

Stanek G1, Wormser GP, Gray J, Strle F.


Most patients with Lyme borreliosis have an excellent prognosis. Although most manifestations of Lyme borreliosis will resolve spontaneously without treatment, antibiotic treatment might speed the resolution of symptoms and signs, and will prevent the development of objective late complications. Precautions to prevent future tick bites should be taken to prevent re-infections.

3. Under our Skin 5min extended trailer

4. Lyme Disease: French Association Launches Alert Against “A Bacterial AIDS”




Tuttle also points out that it appears members of the TBDWG are colluding with the defendants of the RICO lawsuit (Lisa Torrey vs IDSA) as one of those defendants (Eugene Shapiro) is an active member of the Working Group:

For more: